Patents by Inventor Thomas Mock

Thomas Mock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230406909
    Abstract: The present invention relates to monoclonal antibodies binding to the nucleocapsid protein of SARS-CoV-2 virus, nucleic acids encoding said antibody, host cells producing the same, compositions and kits comprising said antibodies, as well as methods of detecting SARS-CoV-2 virus in a sample comprising using said antibodies.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 21, 2023
    Inventors: Michael Gerg, Ute Jucknischke, Ulrike Kurtkaya, Thomas Mock, Michael Schraeml, Sandrine Carolina Stiegler
  • Publication number: 20200400654
    Abstract: The present invention relates to a method for determining an analyte in a sample, comprising a) contacting said sample with at least a first and a second detector compound; b) determining the amount of complexes comprising at least one detector compound; and, c) determining said analyte in a sample based on the result of step b), wherein said first detector compound comprises a first binding moiety and a first label, and said second detector compound comprises a second binding moiety and a second label, and wherein the first label and the second label are non-identical.
    Type: Application
    Filed: September 8, 2020
    Publication date: December 24, 2020
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Johannes Polz, Thomas Mock, Barbara Upmeier, Toralf Zarnt
  • Publication number: 20130333074
    Abstract: The present invention relates to a polypeptide (BIG1) and variants thereof capable of enhancing the rate of cell-division of a microorganism or plant cell, as well as nucleic acid molecules encoding said polypeptides, vectors comprising said nucleic acid molecules and host cells transformed or transfected with said vectors and expressing said polypeptides. The BIG1 polypeptide which has been identified in the marine centric diatom Thalassiosira pseudonana, variants thereof and nucleic acids encoding these may be used in methods of enhancing the rate of cell-division of microorganisms, plant cells or plants which produce useful sub stances or exhibit useful properties, to increase the yield thereof.
    Type: Application
    Filed: February 10, 2012
    Publication date: December 12, 2013
    Applicants: University of Washington through its Center for Commercialization, University of East Anglia
    Inventors: Thomas Mock, Rachel Elizabeth Hipkin